FDA Aiming To Give Full Approval to Pfizer’s Covid Jab by Labor Day to Inspire More ‘Vaccine Confidence’
The US Food and Drug Administration hopes to grant full authorization for Pfizer’s coronavirus vaccine by early September, the New York Times reported, putting the agency slightly ahead of the president’s estimate of “early fall.”
The regulator will look to complete the approval process by the beginning of next month, “multiple people familiar with the plan” told the Times on Tuesday, while the FDA added in comments elsewhere that upgrading authorization from emergency use could “bring additional confidence” in the Pfizer jab.
“Acknowledging the urgency related to the current state of the pandemic, we have taken an all-hands-on-deck approach… in order to complete our review to help combat this pandemic surge,” the agency told the Hill in a statement, though added it “cannot comment” on a specific timeframe.
Our latest stories...